Gulf countries UAE and Bahrain, where third-phase trials of the Sinopharm vaccine were carried out, have both officially registered it for public use after it was previously approved for emergency use for frontline health workers.
from Hindustan Times - world https://ift.tt/3abOrSc
No comments:
Post a Comment